Fate of circulating amino-terminal propeptide of type III procollagen in conscious pigs. 1993

L T Jensen, and J H Henriksen, and J Risteli, and H P Olesen, and M D Nielsen, and I Lorenzen
Department of Rheumatology, University of Copenhagen, Hvidovre Hospital, Denmark.

The amino-terminal propeptide of type III procollagen (PIIINP, M(r) 42,000) is a promising marker for the formation of type III collagen of granulation tissue in experimental and clinical studies. The disposal kinetics of circulating PIIINP is, however, almost unknown. In conscious pigs with a thoracic duct-venous shunt, 125I-labeled PIIINP was injected intravenously. The initial distribution volume was 2.2 liters, which was 1.7 times the plasma volume (P < 0.01). The disappearance curve was three-phased, with an initial steep decline (t1/2 58 min), followed by two slower phases (t1/2 239 min and 289 h). Consecutive gel filtrations showed that the initial slope of the plasma disappearance curve corresponded to the plasma clearance of the intact PIIINP. The initial plasma clearance was 26.5 ml plasma/min, whereas the urinary clearance was 8.7 ml plasma/min (P < 0.01). The other components of the plasma disappearance curve originated from the formation and disappearance of a high and a low molecular weight (MW) fraction as part of the degradation of PIIINP. The high MW fraction (approximately M(r) 90,000) was similar to a previously described, but not further characterized, PIIINP immunoreactive component. The existence of the low MW fraction (approximately M(r) 20,000) has not been reported before. The lymphatic recirculation of intact PIIINP was rapid, and the lymph-serum ratio was almost constant within 1 h of injection. We conclude that the t1/2 of circulating PIIINP is 58 min, that PIIINP escapes the circulation very quickly, and that the degradation of PIIINP includes at least two intermediary steps.

UI MeSH Term Description Entries
D008196 Lymph The interstitial fluid that is in the LYMPHATIC SYSTEM. Lymphs
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011347 Procollagen A biosynthetic precursor of collagen containing additional amino acid sequences at the amino-terminal and carboxyl-terminal ends of the polypeptide chains. Protocollagen,Procollagen Type M
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013552 Swine Any of various animals that constitute the family Suidae and comprise stout-bodied, short-legged omnivorous mammals with thick skin, usually covered with coarse bristles, a rather long mobile snout, and small tail. Included are the genera Babyrousa, Phacochoerus (wart hogs), and Sus, the latter containing the domestic pig (see SUS SCROFA). Phacochoerus,Pigs,Suidae,Warthogs,Wart Hogs,Hog, Wart,Hogs, Wart,Wart Hog
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

L T Jensen, and J H Henriksen, and J Risteli, and H P Olesen, and M D Nielsen, and I Lorenzen
September 1989, Journal of hepatology,
L T Jensen, and J H Henriksen, and J Risteli, and H P Olesen, and M D Nielsen, and I Lorenzen
March 1996, Pancreas,
L T Jensen, and J H Henriksen, and J Risteli, and H P Olesen, and M D Nielsen, and I Lorenzen
December 2012, The British journal of dermatology,
L T Jensen, and J H Henriksen, and J Risteli, and H P Olesen, and M D Nielsen, and I Lorenzen
November 2004, Clinical chemistry,
L T Jensen, and J H Henriksen, and J Risteli, and H P Olesen, and M D Nielsen, and I Lorenzen
April 1988, Clinical chemistry,
L T Jensen, and J H Henriksen, and J Risteli, and H P Olesen, and M D Nielsen, and I Lorenzen
September 2021, Children (Basel, Switzerland),
L T Jensen, and J H Henriksen, and J Risteli, and H P Olesen, and M D Nielsen, and I Lorenzen
April 1989, Cancer research,
L T Jensen, and J H Henriksen, and J Risteli, and H P Olesen, and M D Nielsen, and I Lorenzen
January 1994, Thyroid : official journal of the American Thyroid Association,
L T Jensen, and J H Henriksen, and J Risteli, and H P Olesen, and M D Nielsen, and I Lorenzen
June 1996, Clinical chemistry,
Copied contents to your clipboard!